Cite
HARVARD Citation
Lacosta, A. et al. (n.d.). O1‐10‐03: an Active Anti‐AB40 Vaccine (ABVAC40) Proved to be Safe and Immunogenic in the Phase i Clinical Trial. Alzheimer's & dementia. p. P199. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lacosta, A. et al. (n.d.). O1‐10‐03: an Active Anti‐AB40 Vaccine (ABVAC40) Proved to be Safe and Immunogenic in the Phase i Clinical Trial. Alzheimer's & dementia. p. P199. [Online].